|
Market Cap (18-May) $41,071,320 (780th) |
Close (30-Jun) $0.081 |
Volume (30-Jun) 2,818,974 |
Shortsold (13-Feb) 21,991 (0.00%) (605th) |
|
52w High $0.063 |
52w Low $0.037 |
P/E - |
EPS -0.01 |
PTX released this announcement to the ASX on 3 May 2022, 8:51. The announcement is not marked as price sensitive, and is 22 page(s) in length and 2.94MB in size.
You can view all announcements from PTX and see how they appear on a price chart on the announcements page.
At the date of this announcement, PTX was 0.036% short sold according to ASIC data. It was ranked the 568th most shorted stock on the ASX. It remains ranked 605th as of the latest reported data (13 February 2024).
| Other Recent Announcements from PTX | |
|---|---|
| Application for quotation of securities - PTX | 14 June 2023, 15:38 |
| Two PTX abstracts accepted at prestigious ISCT conference | 16 May 2023, 8:59 |
| Initial Director's Interest Notice | 15 May 2023, 14:31 |
| Prescient to Present at AVID 2022 Meeting | 3 May 2022, 8:51 |
| March 2022 Quarterly Update and Appendix 4C | 29 April 2022, 9:00 |
| Notification of cessation of securities - PTX | 14 April 2022, 16:25 |
| Application for quotation of securities - PTX | 6 April 2022, 14:50 |
You must be logged in to post a reply.
Prescient Therapeutics 